Long-term complications of COVID-19 in Jordan: A study on persisting symptoms and management

Abstract

BackgroundThe COVID-19 pandemic has led to the emergence of a significant health issue – post-COVID-19 syndrome (PCS), characterized by long-term complications in survivors. This study focused on Jordan to assess the prevalence of PCS, associated symptoms, and potential influencing factors, including vaccine types. MethodsA cross-sectional study recruited 500 participants from various regions in Jordan. Structured questionnaires were used to collect data on participant demographics, symptoms, and treatment approaches. The study also investigated the relationship between specific symptoms and different COVID-19 vaccines. ResultsThe majority of participants were aged 25–55 years, well-educated, and had chronic comorbidities. Notable sensory complications included anosmia and dysgeusia, while psychiatric symptoms and reduced sexual desire were also prevalent. Interestingly, Pfizer® and Sinopharm® vaccines were linked to distinct symptom patterns. Participants pursued various treatments, including pharmacological and non-pharmacological options such as honey and vitamins. Relatives, friends, and pharmacists were the primary sources of information for participants. ConclusionThe study underscores the significant burden of PCS in Jordan and highlights the necessity for tailored interventions, mental health support, and effective communication strategies in post-COVID-19 care. The findings contribute to a comprehensive understanding of PCS and offer valuable guidance for healthcare systems in addressing the evolving healthcare needs of COVID-19 survivors.